1. Home
  2. KRRO vs SMID Comparison

KRRO vs SMID Comparison

Compare KRRO & SMID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$13.47

Market Cap

150.0M

Sector

Health Care

ML Signal

HOLD

Logo Smith-Midland Corporation

SMID

Smith-Midland Corporation

HOLD

Current Price

$28.34

Market Cap

151.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRRO
SMID
Founded
2014
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
150.0M
151.1M
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
KRRO
SMID
Price
$13.47
$28.34
Analyst Decision
Buy
Analyst Count
12
0
Target Price
$34.80
N/A
AVG Volume (30 Days)
266.1K
6.0K
Earning Date
05-06-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
866.67
EPS
N/A
1.96
Revenue
$6,392,000.00
$78,508,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$14.03
Revenue Growth
181.46
31.77
52 Week Low
$5.20
$25.60
52 Week High
$55.89
$43.62

Technical Indicators

Market Signals
Indicator
KRRO
SMID
Relative Strength Index (RSI) 60.38 36.18
Support Level $12.17 $25.60
Resistance Level $14.96 $37.20
Average True Range (ATR) 0.99 2.17
MACD 0.31 -0.23
Stochastic Oscillator 62.16 25.11

Price Performance

Historical Comparison
KRRO
SMID

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

Share on Social Networks: